Name: OPIANT PHARMACEUTICALS INC (OPNT) Stock
Brand: OPIANT PHARMACEUTICALS INC
Rating: 4 (3 reviews)

OPNT Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: Benzinga

Indivior Acquires Opiant Pharmaceuticals Strengthening Its Addiction Treatment And Science Portfolio

3 years ago - By: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC

3 years ago - By: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC

3 years ago - By: Seeking Alpha - Mentions: HZNP AMGN

Horizon, Opiant stock fall amid Elizabeth Warren concerned about pharma deals

3 years ago - By: Seeking Alpha - Mentions: HZNP AMGN HZN

Horizon, Opiant stock fall on report Elizabeth Warren concerned about pharma deals

3 years ago - By: Seeking Alpha

Opiant wins FDA priority review for opioid overdose therapy (NASDAQ:OPNT)

3 years ago - By: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose

3 years ago - By: Kahn Swick & Foti, LLC

OPIANT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Opiant Pharmaceuticals, Inc. - OPNT

3 years ago - By: Benzinga

Analyzing Opiant Pharma's Short Interest

3 years ago - By: Indivior

Indivior Capital Markets Day Highlights Strategy for Shareholder Value Creation and Attractive Medium-Term Profitable Growth Outlook

3 years ago - By: Opiant Pharmaceuticals

Opiant Pharmaceuticals Announces Completion of Rolling NDA Submission for OPNT003, Nasal Nalmefene, for Opioid Overdose

3 years ago - By: Kahn Swick & Foti, LLC

OPIANT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Opiant Pharmaceuticals, Inc. - OPNT

3 years ago - By: Weiss Law

SHAREHOLDER ALERT: Weiss Law Investigates Opiant Pharmaceuticals, Inc.

3 years ago - By: InvestorPlace - Mentions: PRTY BBBY MNDY

Party City Layoffs 2022: What to Know About the PRTY Job Cuts

3 years ago - By: InvestorPlace - Mentions: MNDY ASTS SEV

Why Is Opiant Pharma (OPNT) Stock Up 116% Today?

3 years ago - By: Halper Sadeh LLC

OPNT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Opiant Pharmaceuticals, Inc. Is Fair to Shareholders

3 years ago - By: Ademi LLP

OPIANT PHARMACEUTICALS INC (OPNT) Stock News

OPNT Latest News, Press Relases and Analysis

Indivior Acquires Opiant Pharmaceuticals Strengthening Its Addiction Treatment And Science Portfolio

Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC

Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC

Horizon, Opiant stock fall amid Elizabeth Warren concerned about pharma deals

Horizon, Opiant stock fall on report Elizabeth Warren concerned about pharma deals

Opiant wins FDA priority review for opioid overdose therapy (NASDAQ:OPNT)

Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose

OPIANT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Opiant Pharmaceuticals, Inc. - OPNT

Analyzing Opiant Pharma's Short Interest

Indivior Capital Markets Day Highlights Strategy for Shareholder Value Creation and Attractive Medium-Term Profitable Growth Outlook

Opiant Pharmaceuticals Announces Completion of Rolling NDA Submission for OPNT003, Nasal Nalmefene, for Opioid Overdose

OPIANT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Opiant Pharmaceuticals, Inc. - OPNT

SHAREHOLDER ALERT: Weiss Law Investigates Opiant Pharmaceuticals, Inc.

Party City Layoffs 2022: What to Know About the PRTY Job Cuts

Why Is Opiant Pharma (OPNT) Stock Up 116% Today?

OPNT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Opiant Pharmaceuticals, Inc. Is Fair to Shareholders

Shareholder Alert: Ademi LLP investigates whether Opiant Pharmaceuticals Inc. has obtained a Fair Price in its transaction with Indivior